US Broker Ratings

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Navigating Challenges in the Medical Device Sector

SANUWAVE Health, Inc. (SNWV), a player in the healthcare sector specializing in medical devices, is drawing attention with its innovative approach to regenerative medicine. The company’s..

Olema Pharmaceuticals, Inc. (OLMA) Stock Analysis: Unlocking a 387% Upside Potential in Biotech

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA), a clinical-stage biopharmaceutical company specializing in therapies for women’s cancers, is presenting a compelling investment opportunity with a staggering potential upside..

Spok Holdings, Inc. (SPOK) Stock Analysis: High Dividend Yield Raises Investor Eyebrows

Spok Holdings, Inc. (NASDAQ: SPOK) has captured the attention of investors with its notably generous dividend yield of 12.28%, an aspect that stands out in the..

ClearPoint Neuro Inc. (CLPT) Stock Analysis: Potential 122% Upside in the Healthcare Sector

ClearPoint Neuro Inc. (NASDAQ: CLPT) presents a compelling opportunity for investors seeking exposure to the burgeoning medical devices sector. Operating within the healthcare industry, the company’s..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 59% Upside in the Biotech Arena

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotechnology sector with its ambitious focus on precision oncology, particularly targeting the RAS/MAPK pathway-driven cancers. With a..

Zhengye Biotechnology Holding L (ZYBT) Stock Analysis: Navigating Challenges Amidst Volatile Market Conditions

Zhengye Biotechnology Holding L (ZYBT), a niche player in the healthcare sector, is making strides in the competitive drug manufacturing industry with a focus on specialty..

Evolent Health, Inc (EVH) Stock Analysis: Unveiling a 26.93% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH) stands at the forefront of healthcare innovation, offering a unique investment opportunity with a compelling 26.93% potential upside, according to analyst..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Exploring a 5.63% Potential Upside in the Biotech Sector

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH), a prominent player in the biotechnology industry, is making waves with its innovative approach to treating autoimmune diseases. With a market..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Healthcare Growth Story with 10% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector with its promising growth trajectory and robust analyst support. With a market capitalization..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Over 400% Potential Upside with Strong Buy Ratings

Structure Therapeutics Inc. (NASDAQ: GPCR) stands out in the biotechnology sector with a remarkable potential upside of over 400%, according to analysts. As a clinical-stage biopharmaceutical..

Establishment Labs Holdings Inc (ESTA): Analyst Consensus Predicts Nearly 50% Upside Potential

Establishment Labs Holdings Inc (NASDAQ: ESTA), a burgeoning player in the medical device industry, is capturing investor attention with a compelling growth narrative and significant upside..

Mineralys Therapeutics, Inc. (MLYS): Investor Outlook with a 125% Potential Upside and Strong Buy Ratings

Mineralys Therapeutics, Inc. (MLYS), a promising player in the biotechnology sector, is making waves in the healthcare industry with its cutting-edge approach to tackling cardiorenal conditions...

Artivion, Inc. (AORT) Stock Analysis: Exploring a 78% Potential Upside in the Medical Devices Sector

Artivion, Inc. (AORT) stands as a prominent player in the healthcare sector, specifically within the niche of medical devices. Headquartered in Kennesaw, Georgia, Artivion is a..

agilon health, inc. (AGL) Stock Analysis: Navigating Healthcare with a 28.22% Potential Upside

agilon health, inc. (NYSE: AGL) is carving a niche in the healthcare sector, specifically in medical care facilities, by delivering specialized services to seniors through primary..

Adaptive Biotechnologies (ADPT) Stock Analysis: Evaluating a 15% Upside Potential in the Healthcare Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a pioneering force in the healthcare sector, stands at the forefront of immune medicine innovation with its cutting-edge diagnostics and research..

Amphastar Pharmaceuticals (AMPH) Investor Outlook: Analyzing Growth Potential Amidst a Mixed Analyst Consensus

Investors eyeing Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) should be prepared for a complex landscape of opportunity and risk as this biopharmaceutical firm continues to navigate the..

Neogen Corporation (NEOG) Investor Outlook: Analyzing the 14.66% Potential Upside in Medical Devices

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in medical devices, continues to capture investor attention with a notable 14.66% potential upside..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 58.71% Potential Upside in Biotech Innovations

Biohaven Ltd. (NASDAQ: BHVN) stands at the intersection of innovation and opportunity within the biotechnology sector. With a market capitalization of $2.18 billion, this U.S.-based healthcare..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 45.7% Potential Upside

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), a key player in the healthcare sector within the specialty and generic drug manufacturing industry, is drawing significant attention from investors...

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: A Biotech with 293% Upside Potential

Ocular Therapeutix, Inc. (NASDAQ: OCUL), a notable player in the biotechnology sector, has recently captured the attention of investors with its remarkable potential upside. Specializing in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds